GB1115893A - Pharmaceutical anti-allergic compositions - Google Patents

Pharmaceutical anti-allergic compositions

Info

Publication number
GB1115893A
GB1115893A GB1681/67A GB168167A GB1115893A GB 1115893 A GB1115893 A GB 1115893A GB 1681/67 A GB1681/67 A GB 1681/67A GB 168167 A GB168167 A GB 168167A GB 1115893 A GB1115893 A GB 1115893A
Authority
GB
United Kingdom
Prior art keywords
diol
lower alkyl
pharmaceutical anti
allergic compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1681/67A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scherico Ltd
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of GB1115893A publication Critical patent/GB1115893A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions for treating allergies comprise a carrier and, as active ingredient 6a - halo - or 6a - lower alkyl - 6 - lower alkyl derivatives of 1, 4 - pregnadene - 17a , 21 - diol - 3, 20 - diene or 1, 4, 9(11) - pregnatriene - 17a , 21 - diol - 3, 20 - dione or a 21 - ester thereof. The term "lower" signifies groups containing up to 4 carbon atoms. They may be in conventional forms for oral, parenteral, topical or ophthalmic administration and may also include antihistamines, antibiotics adsenocartical steroids; caffeine, aspirin and acetophenetidine.
GB1681/67A 1966-01-14 1967-01-12 Pharmaceutical anti-allergic compositions Expired GB1115893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52067566A 1966-01-14 1966-01-14

Publications (1)

Publication Number Publication Date
GB1115893A true GB1115893A (en) 1968-05-29

Family

ID=24073614

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1681/67A Expired GB1115893A (en) 1966-01-14 1967-01-12 Pharmaceutical anti-allergic compositions

Country Status (4)

Country Link
US (1) US3463852A (en)
FR (1) FR6111M (en)
GB (1) GB1115893A (en)
NL (1) NL6700544A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156643A3 (en) * 1984-03-28 1986-08-20 The Upjohn Company Ester prodrugs of steroids
GB2355657A (en) * 1999-10-27 2001-05-02 Phytopharm Plc Inhibitors of gastric acid secretion
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US10857161B2 (en) * 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051241A (en) * 1975-03-10 1977-09-27 Syntex (U.S.A.) Inc. Method of treating diseases by daily administration of 6-chloro-11β,17α,21-trihydroxypregna-1,4,6-triene-3,20-dione
DE3071122D1 (en) * 1979-11-16 1985-10-31 Sterosynt Ltd 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates
US4902681A (en) * 1987-08-27 1990-02-20 University Of Pennsylvania Inhibition of immune clearance using progesterone analogues
US4908358A (en) * 1987-08-27 1990-03-13 Trustees Of The University Of Pennsylvania Inhibition of immune clearance using progesterone analogues
FR2758083B1 (en) * 1997-01-03 1999-02-05 Oreal COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING A DISPERSION OF A POLYMERIC SYSTEM AND USE OF THE SYSTEM AS A TENSIONER
US20070292468A1 (en) * 2006-06-14 2007-12-20 Joel Studin Coated jewelry articles to reduce skin irritation
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH464183A (en) * 1958-04-12 1968-10-31 Philips Nv Process for making new steroids
GB933859A (en) * 1958-09-06 1963-08-14 Syntex S.A.
US3198792A (en) * 1962-06-12 1965-08-03 Philips Corp 10alpha methyl, 9beta hormonal steroids

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156643A3 (en) * 1984-03-28 1986-08-20 The Upjohn Company Ester prodrugs of steroids
GB2355657A (en) * 1999-10-27 2001-05-02 Phytopharm Plc Inhibitors of gastric acid secretion
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
US10857161B2 (en) * 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US11833159B2 (en) 2008-05-28 2023-12-05 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en) 2019-03-07 2022-10-18 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
FR6111M (en) 1968-06-17
NL6700544A (en) 1967-07-17
US3463852A (en) 1969-08-26

Similar Documents

Publication Publication Date Title
GB1115893A (en) Pharmaceutical anti-allergic compositions
MY103280A (en) Steroid lotion
ES483894A1 (en) Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same.
IE39738L (en) Triamcinolone derivative
IL34713A0 (en) Anaesthetic pharmaceutical preparations containing steroids of the pregnane series and some new pregnane derivatives
GB1123770A (en) 2-cyano-3-oxo-steroids
GB1341794A (en) Medicament for the treatment of hepatic disorders
IE41287L (en) Steroid pharmaceutical composition
FR2096712A1 (en) Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
NL167691B (en) PROCESS FOR THE PREPARATION OR MANUFACTURE OF THERAPEUTIC PREPARATIONS FOR Soothing and relieving pains of different origins, as well as for treating rheumatic, arthritic and other inflammatory diseases, in which they are used in a wide variety. A PROCESS FOR THE PREPARATION OF IMIDAZOLE COMPOUNDS AND THE PHARMACEUTICALLY ACCEPTABLE ADDITION METHOD FOR THE PREPARATION OR MANUFACTURE OF THERAPEUTIC PREPARATIONS FOR Soothing and alleviating pain of different origins,
GB1287602A (en) 4,6-DICHLORO-Delta<4.6>-OESTRADIENES
GB1193464A (en) Steroidal Esters, Processes for Making them, and Therapeutic Compositions Containing them
GB1270049A (en) New pharmaceutical product
GB1098151A (en) Membrane penetrant compositions comprising dialkyl sulfoxides
BE894860A (en) Prevention of breast cancer recurrence following mastectomy - by admin. of 17 alpha acyloxy 6:methyl pregna 4,6-dien 3,20:di:one
USD188381S (en) Display plaque for vehicles
IL36608A (en) 16alpha,17alpha-dihydroxy-21-fluoro-pregna-4,6-diene-3,20-diones and derivatives thereof,their manufacture and pharmaceutical compositions containing them
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
IL32936A0 (en) Androstane and pregnane derivatives and pharmaceutical compositions containing them
GB1430726A (en) Pharmaceutical preparations containing resorcinol deirvatives
GB1174362A (en) Oral Medicants for Haemorrhoids.
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
CA626911A (en) Use of vitamin d in preventing hypercalcuria resulting from adrenal cortical steroid administration
AU414340B2 (en) Medicinal compositions for administration to animals and process for administering same
GB1129134A (en) Improvements in compositions containing nicotinates